Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation

Role of eNOS phosphorylation at Tyr83

David J Fulton, Ling Ruan, Sarika G. Sood, Chunying Li, Qian Zhang, Richard C Venema

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Tyr83 in endothelial nitric oxide synthase (eNOS) has been identified previously as a site of Src kinase-mediated phosphorylation of eNOS in bovine aortic endothelial cells (BAECs) that is phosphorylated in response to oxidant stress. In the present study, we have used a phospho-specific antibody to show that Tyr83 in eNOS is also phosphorylated in both BAECs and intact blood vessel segments in response to treatment with a variety of different eNOS-activating agonists, including thapsigargin, vascular endothelial growth factor, bradykinin, ATP, sphingosine-1-phosphate, estrogen, angiopoietin, and acetylcholine. Agonist stimulation of eNOS Tyr83 phosphorylation as well as agonist stimulation of endothelial NO release in BAECs is blocked by Src kinase inhibition by either 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo [3,4-d] pyrimidine (PP2) or by dominant negative Src. Mutation of Tyr83 to a nonphosphorylatable Phe blocks agonist stimulation of NO release from eNOS-reconstituted eNOS knockdown endothelial cells. Mutation of Tyr83 also attenuates agonist-induced relaxation of eNOS-reconstituted aortic rings from eNOS knockout mice. Phosphorylation of eNOS at Tyr83 thus appears to be a common covalent modification that is induced, not only by oxidant stress but also by other physiologically relevant extracellular signals known to be important in regulation of eNOS activity in vivo. Moreover, our results demonstrate an important role for Src-mediated phosphorylation of eNOS at Tyr83 in agonist stimulation of eNOS activation and vascular relaxation.

Original languageEnglish (US)
Pages (from-to)497-504
Number of pages8
JournalCirculation research
Volume102
Issue number4
DOIs
StatePublished - Feb 1 2008

Fingerprint

Nitric Oxide Synthase Type III
Blood Vessels
Phosphorylation
Endothelial Cells
src-Family Kinases
Oxidants
Phospho-Specific Antibodies
Angiopoietins
Mutation
Thapsigargin
Bradykinin
Knockout Mice
Vascular Endothelial Growth Factor A
Acetylcholine
Estrogens
Adenosine Triphosphate

Keywords

  • Endothelium
  • Nitric oxide synthase
  • Src kinase

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation : Role of eNOS phosphorylation at Tyr83. / Fulton, David J; Ruan, Ling; Sood, Sarika G.; Li, Chunying; Zhang, Qian; Venema, Richard C.

In: Circulation research, Vol. 102, No. 4, 01.02.2008, p. 497-504.

Research output: Contribution to journalArticle

Fulton, David J ; Ruan, Ling ; Sood, Sarika G. ; Li, Chunying ; Zhang, Qian ; Venema, Richard C. / Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation : Role of eNOS phosphorylation at Tyr83. In: Circulation research. 2008 ; Vol. 102, No. 4. pp. 497-504.
@article{94fb755bd827488585078d3f23662655,
title = "Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation: Role of eNOS phosphorylation at Tyr83",
abstract = "Tyr83 in endothelial nitric oxide synthase (eNOS) has been identified previously as a site of Src kinase-mediated phosphorylation of eNOS in bovine aortic endothelial cells (BAECs) that is phosphorylated in response to oxidant stress. In the present study, we have used a phospho-specific antibody to show that Tyr83 in eNOS is also phosphorylated in both BAECs and intact blood vessel segments in response to treatment with a variety of different eNOS-activating agonists, including thapsigargin, vascular endothelial growth factor, bradykinin, ATP, sphingosine-1-phosphate, estrogen, angiopoietin, and acetylcholine. Agonist stimulation of eNOS Tyr83 phosphorylation as well as agonist stimulation of endothelial NO release in BAECs is blocked by Src kinase inhibition by either 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo [3,4-d] pyrimidine (PP2) or by dominant negative Src. Mutation of Tyr83 to a nonphosphorylatable Phe blocks agonist stimulation of NO release from eNOS-reconstituted eNOS knockdown endothelial cells. Mutation of Tyr83 also attenuates agonist-induced relaxation of eNOS-reconstituted aortic rings from eNOS knockout mice. Phosphorylation of eNOS at Tyr83 thus appears to be a common covalent modification that is induced, not only by oxidant stress but also by other physiologically relevant extracellular signals known to be important in regulation of eNOS activity in vivo. Moreover, our results demonstrate an important role for Src-mediated phosphorylation of eNOS at Tyr83 in agonist stimulation of eNOS activation and vascular relaxation.",
keywords = "Endothelium, Nitric oxide synthase, Src kinase",
author = "Fulton, {David J} and Ling Ruan and Sood, {Sarika G.} and Chunying Li and Qian Zhang and Venema, {Richard C}",
year = "2008",
month = "2",
day = "1",
doi = "10.1161/CIRCRESAHA.107.162933",
language = "English (US)",
volume = "102",
pages = "497--504",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation

T2 - Role of eNOS phosphorylation at Tyr83

AU - Fulton, David J

AU - Ruan, Ling

AU - Sood, Sarika G.

AU - Li, Chunying

AU - Zhang, Qian

AU - Venema, Richard C

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Tyr83 in endothelial nitric oxide synthase (eNOS) has been identified previously as a site of Src kinase-mediated phosphorylation of eNOS in bovine aortic endothelial cells (BAECs) that is phosphorylated in response to oxidant stress. In the present study, we have used a phospho-specific antibody to show that Tyr83 in eNOS is also phosphorylated in both BAECs and intact blood vessel segments in response to treatment with a variety of different eNOS-activating agonists, including thapsigargin, vascular endothelial growth factor, bradykinin, ATP, sphingosine-1-phosphate, estrogen, angiopoietin, and acetylcholine. Agonist stimulation of eNOS Tyr83 phosphorylation as well as agonist stimulation of endothelial NO release in BAECs is blocked by Src kinase inhibition by either 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo [3,4-d] pyrimidine (PP2) or by dominant negative Src. Mutation of Tyr83 to a nonphosphorylatable Phe blocks agonist stimulation of NO release from eNOS-reconstituted eNOS knockdown endothelial cells. Mutation of Tyr83 also attenuates agonist-induced relaxation of eNOS-reconstituted aortic rings from eNOS knockout mice. Phosphorylation of eNOS at Tyr83 thus appears to be a common covalent modification that is induced, not only by oxidant stress but also by other physiologically relevant extracellular signals known to be important in regulation of eNOS activity in vivo. Moreover, our results demonstrate an important role for Src-mediated phosphorylation of eNOS at Tyr83 in agonist stimulation of eNOS activation and vascular relaxation.

AB - Tyr83 in endothelial nitric oxide synthase (eNOS) has been identified previously as a site of Src kinase-mediated phosphorylation of eNOS in bovine aortic endothelial cells (BAECs) that is phosphorylated in response to oxidant stress. In the present study, we have used a phospho-specific antibody to show that Tyr83 in eNOS is also phosphorylated in both BAECs and intact blood vessel segments in response to treatment with a variety of different eNOS-activating agonists, including thapsigargin, vascular endothelial growth factor, bradykinin, ATP, sphingosine-1-phosphate, estrogen, angiopoietin, and acetylcholine. Agonist stimulation of eNOS Tyr83 phosphorylation as well as agonist stimulation of endothelial NO release in BAECs is blocked by Src kinase inhibition by either 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo [3,4-d] pyrimidine (PP2) or by dominant negative Src. Mutation of Tyr83 to a nonphosphorylatable Phe blocks agonist stimulation of NO release from eNOS-reconstituted eNOS knockdown endothelial cells. Mutation of Tyr83 also attenuates agonist-induced relaxation of eNOS-reconstituted aortic rings from eNOS knockout mice. Phosphorylation of eNOS at Tyr83 thus appears to be a common covalent modification that is induced, not only by oxidant stress but also by other physiologically relevant extracellular signals known to be important in regulation of eNOS activity in vivo. Moreover, our results demonstrate an important role for Src-mediated phosphorylation of eNOS at Tyr83 in agonist stimulation of eNOS activation and vascular relaxation.

KW - Endothelium

KW - Nitric oxide synthase

KW - Src kinase

UR - http://www.scopus.com/inward/record.url?scp=41949128419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949128419&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.107.162933

DO - 10.1161/CIRCRESAHA.107.162933

M3 - Article

VL - 102

SP - 497

EP - 504

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 4

ER -